Biological E has received approval for conducting phase II/III human clinical trial of Covid-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology...

The CSIR and Laxai Life Sciences Private Limited have initiated phase II clinical trials of anti-helminitic drug Niclosamide' for the treatment of Covid-19 patients, a statement said on Sunday. T...

The second dry run for Covid vaccination will be held on Friday across 23 districts of Bengal. Each district will have three vaccination centres. The first dry run was restricted to three centres in ...

The Indian government is making all efforts to support and promote the development of Covid-19 vaccine, however, there is a need to strengthen cold chain logistics and remove vaccine hesitancy, expert...

Two years ago, Sanjay Singh, a biochemist and chief executive officer of a Pune-based biotechnology company producing drugs for cancers and strokes, turned his attention to a new “platform&rdquo...

Researchers at Imperial College London are planning to deliberately infect healthy volunteers with the coronavirus early next year as part of the world’s first effort to study how people immunis...

India’s department of biotechnology has selected 10 cities where several thousand healthy volunteers could join the anticipated large-scale clinical trials to assess the efficacy of candidate va...

We read a recent opinion article titled, “An opaque model of drug approval”, in The Telegraph with interest. We respectfully disagree with the author, and appreciate the opportun...

The phase-I human clinical trial of India's first indigenously-developed vaccine against novel coronavirus, Covaxin, began at the AIIMS in New Delhi on Friday with the first dose of the injection ...

The candidate vaccine against the new coronavirus disease developed by Oxford researchers and shown as safe and able to induce promising immune responses will be tested in India, among other countries...